{"DataElement":{"publicId":"2797645","version":"2","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Involvement Maximum Severity Type","preferredDefinition":"A description of the maximum severity of acute graft versus host disease upper gastrointestinal tract involvement.","longName":"2797641v1.0:2797643v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2797641","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Involvement Maximum Severity","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum._To have a connection by participation or association or use; sharing in an activity or process._The largest possible quantity or degree._Used of the degree of something undesirable e.g. pain or weather; also, strictness.","longName":"AGVHD_UP_GT_IN_MX_SV","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2813543","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Involvement","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:No Value Exists:To have a connection by participation or association or use; sharing in an activity or process.","longName":"C4980:C33837:C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Gastrointestinal Tract","conceptCode":"C33837","definition":"The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DA45D3E-65D3-AF36-E040-BB89A6432C25","latestVersionIndicator":"Yes","beginDate":"2008-12-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-09","modifiedBy":"ONEDATA","dateModified":"2008-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2797604","version":"1","preferredName":"Maximum Severity","preferredDefinition":"the largest possible quantity or degree.:Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"C25564:C25676","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF3F82E-0B53-6059-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"ONEDATA","dateModified":"2008-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF650E2-CB1A-2AE7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2797643","version":"2","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.","longName":"2797643v2.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":"AGVHD Upper GI Stage 0","ValueMeaning":{"publicId":"5132197","version":"1","preferredName":"AGVHD Upper GI Stage 0","longName":"5132197","preferredDefinition":"No persistent nausea or vomiting","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-1612-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-162B-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 1","valueDescription":"AGVHD Upper GI Stage 1","ValueMeaning":{"publicId":"5132196","version":"1","preferredName":"AGVHD Upper GI Stage 1","longName":"5132196","preferredDefinition":"Persistent nausea or vomiting","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-15EF-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-1608-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2955349","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.:Severity; used of the degree of something undesirable e.g. pain or weather.:Type; a subdivision of a particular kind of thing.","longName":"C4980:C33837:C25676:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Upper Gastrointestinal Tract","conceptCode":"C33837","definition":"The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7674DB27-68F6-E5C0-E040-BB89AD431D0B","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-15A0-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"},{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"HPST_AGHD_agvhd_max_stg_up_int","type":"NMDP_FN","context":"NHLBI"},{"name":"TPST_GVHD_agvh_max_stge_up_int","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the maximum severity","type":"Preferred Question Text","description":"What was the maximum severity of acute graft versus host disease upper gastrointestinal tract involvement?","url":null,"context":"NHLBI"},{"name":"Upper intestinal tract:","type":"Alternate Question Text","description":"Upper intestinal tract:","url":null,"context":"NHLBI"},{"name":"List the maximum severity of upper intestinal tract involvement:","type":"Alternate Question Text","description":"List the maximum severity of upper intestinal tract involvement:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2797645","type":"BRIDG Mapping Path","description":"PerformedObservation > PerformedClinicalInterpretation.value WHERE PerformedObservation > DefinedObservation.nameCode = \"assess severity\" AND PerformedObservation.targetAnatomicSiteCode = \"upper intestinal tract\" AND PerformedObservation > AssessedResultRelationship > PerformedDiagnosis.value = \"GVHD\" AND PerformedDiagnosis.diseaseStatusCode = \"Acute\" AND AssessedResultRelationship.typeCode = \"assessment\"","url":null,"context":"NHLBI"},{"name":"Upper intestinal tract","type":"Application Standard Question Text","description":"Upper intestinal tract","url":null,"context":"NHLBI"},{"name":"Upper intestinal tract","type":"Alternate Question Text","description":"Upper intestinal tract","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-163F-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"KUMMEROA","dateModified":"2019-06-06","changeDescription":". Added Field Name for 2450. AK 6/6/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}